Study suggests miR-377 as potential therapeutic target for prostate cancer

FHS
May 22, 2024
7:10 pm

A new research paper was published in Genes & Cancer on May 16, 2024, entitled, “Inhibitory effect of miR-377 on the proliferative and invasive behaviors of prostate cancer cells through the modulation of MYC mRNA via its interaction with BCL-2/Bax, PTEN, and CDK4.”

New AI tool revolutionizes protein function prediction

A new artificial intelligence (AI) tool that draws logical inferences about the function of unknown proteins promises to help scientists unravel the inner workings of

February 14, 2024

Social Anxiety Nasal Spray Win; Racemic Ketamine vs Esketamine; Is AI Pro-Anorexia?

The investigational nasal spray fasedienol significantly improved social anxiety disorder symptoms during a public speaking challenge compared with placebo in the phase III PALISADE-2 trial,

August 10, 2023

Data Insights – Pharmaceutical Technology

By Company Name No Filter Selected Bristol-Myers Squibb (346) Merck (243) Novartis (232) AstraZeneca (220) Pfizer (217) F. Hoffmann-La Roche (169) AbbVie (150) BeiGene (144)

March 14, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.